Annie Wong, Consultant Medical Oncologist at Peter MacCallum Cancer Centre and Senior Lecturer at The University of Auckland and University of Otago, shared on LinkedIn:
“Picture is worth a thousand words.
Across the Asia-Pacific, access to WHO essential cancer medicines remains deeply unequal, with many patients facing substantial out-of-pocket costs.
And for cancer medicines with high clinical benefit, as defined by the ESMO-MCBS, the access gap is even greater.
Come to our session at ESMO Congress to further the discussion on structural and regulatory changes needed to get the best treatment to patients everywhere.
ESMO – European Society for Medical Oncology Cancer Medicines Committee.”
Title: Asia-Pacific analysis of ESMO study on availability, out-of-pocket costs (OPC) and accessibility of antineoplastic medicines
Authors: A. N. M. Wong, P. Franco, H. S. Sheikh, O. Pitiyarachchi, N. Prasongsook, M. V. Ordinario, R. Velasco, V. Agarwala, A. Dinh TL, A. Kapoor, T. Kogawa, H. H. Loong, R. Lui, H. G. Luna, M. Matias, K. Y. Y. Ng, V. Selvaraj, A. Sunggoro, L. Thamlikitkul, N. Cherny
Read the Full Article.
Other articles featuring Annie Wong on OncoDaily.
